Search Filters

Search Results

Found 910 results

510(k) Data Aggregation

    K Number
    K252217

    Validate with FDA (Live)

    Device Name
    CT VScore+
    Date Cleared
    2025-11-28

    (136 days)

    Product Code
    Regulation Number
    892.1750
    Reference & Predicate Devices
    Predicate For
    N/A
    Why did this record match?
    510k Summary Text (Full-text Search) :

    MINNETONKA, MN 55343

    Re: K252217
    Trade/Device Name: CT VScore+
    Regulation Number: 21 CFR 892.1750
    system |
    | Common Name | System, X-Ray, Tomography, Computed |
    | Regulation Number | 21 CFR 892.1750
    system |
    | Common Name | System, X-Ray, Tomography, Computed |
    | Regulation Number | 21 CFR 892.1750

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    CT VScore+ is a software application intended for non-invasive evaluation of calcified lesions of the coronary arteries based on ECG-gated, non-contrast cardiac CT images for patients aged 30 years or older. The device automatically generates calcium scores for the coronary arteries (combined LM+LAD, RCA, LCX) and highlights the segmented calcium on the original CT image. The device also offers the option for the user to display the calcium scores in the context of reference data from the MESA and Hoff-Kondos databases.

    The segmented arteries include combined LM+LAD, RCA, and LCX. To obtain separate LM and LAD results, the user must perform manual segmentation. The segmentation map of calcifications is intended for informational use only and is not intended for detection or diagnostic purposes. The 3D Calcium View output is provided strictly as an informational and supplementary output and should never be used alone as the method of reviewing the calcium segmentation.

    Device Description

    CT VScore+ is a software application intended for non-invasive evaluation of calcified lesions of the coronary arteries based on ECG-gated, non-contrast cardiac CT images for patients aged 30 years or older. The application runs on the Vitrea platform.

    The device automatically generates Agatston and volume calcium scores for each of the coronary arteries (combined LM+LAD, RCA, LCX) based on the volume and density of the calcium deposits and highlights the Segmented calcium on the original CT image. The device also offers the option for the user to display the calcium scores in the context of reference data from the MESA and Hoff-Kondos databases.

    The software uses deep learning-based segmentation methods. Users can edit the automated segmentation, including manually assigning calcifications to anatomical structures.

    The device automatically outputs a combined LM+LAD score as the final automated output. To obtain separate LM and LAD results, the user must perform manual segmentation using the provided editing tools.

    The device is Software as a Medical Device (SaMD) that operates on ECG-gated, non-contrast cardiac CT DICOM images.

    The device does not interact directly with the patient. The device is a software application that runs on the Vitrea platform and processes ECG-gated non-contrast cardiac CT DICOM images. The device automatically generates Agatston and volume calcium scores for each of the coronary arteries (LAD+LM, RCA, LCX) based on the volume and density of the calcium deposits and highlights the segmented calcium on the original CT image. Results can be exported to image management, archival, or reporting systems that support DICOM standards for further review and interpretation.

    Results can also be saved in DICOM Structured Reports (DICOM SR) format.

    AI/ML Overview

    The CT VScore+ device is a software application for non-invasive evaluation of calcified lesions of the coronary arteries from ECG-gated, non-contrast cardiac CT images. The study presented demonstrates the analytical validity and performance of the device against predefined acceptance criteria.

    1. Table of Acceptance Criteria and Reported Device Performance

    MetricAcceptance CriteriaReported Device Performance
    Total Agatston Score ICC(2,1)> 0.950.997 [95% CI: 0.996–0.998]
    Total Volume Score ICC(2,1)> 0.950.996 [95% CI: 0.995–0.997]
    Per-Vessel ICC - LCx> 0.900.937
    Per-Vessel ICC - RCA> 0.900.990
    Per-Vessel ICC - LM+LAD> 0.900.983
    CAC-DRS 4-Class Kappa> 0.900.959 [95% CI: 0.936–0.982]
    CAC Standard 5-Class Kappa> 0.900.958 [95% CI: 0.938–0.978]
    Voxelwise Dice ScoreInformational Metric0.920 overall; LCx 0.874, RCA 0.883, LM+LAD 0.958

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size (Test Set): 236 independent cases.
    • Data Provenance: The pivotal validation dataset was sourced from diverse U.S. sites and scanner vendors. The development dataset, from which the test set was independent, included data from four institutions (two US sites and two Japanese sites). The 236 cases for validation were "independent" at both the patient level and the site level from the development dataset. It is retrospective data.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    • Number of Experts: Three.
    • Qualifications of Experts: U.S. board-certified radiologists/cardiologists. (Specific years of experience are not mentioned).

    4. Adjudication Method for the Test Set

    • Adjudication Method: A "2+1 consensus process" was used. This typically means that if two experts agree, their consensus defines the ground truth. If there's a disagreement between two, the third expert acts as a tie-breaker or adjudicator.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    • The provided document does not mention a multi-reader multi-case (MRMC) comparative effectiveness study to assess the effect size of human readers improving with AI vs. without AI assistance. The study focuses on the standalone performance of the AI algorithm against a consensus ground truth.

    6. Standalone Performance Study (Algorithm Only)

    • Yes, a standalone performance study was conducted. The metrics listed in the table (ICC, Kappa, Dice Score) directly assess the performance of the CT VScore+ algorithm in isolation against the established ground truth.

    7. Type of Ground Truth Used

    • Type of Ground Truth: Expert consensus. Specifically, the reference standard ground truth was established by consensus manual scoring on an FDA-cleared device (Vitrea CT VScore, K243240) and a 2+1 consensus process by three U.S. board-certified radiologists/cardiologists.

    8. Sample Size for the Training Set

    • Sample Size (Training Set): 94 cases (part of the 210 cases used for development).

    9. How the Ground Truth for the Training Set Was Established

    • The document implies that the ground truth for the training set (part of the development dataset) was established similarly to the validation set's ground truth, i.e., "by consensus manual scoring on an FDA-cleared device (Vitrea CT VScore, K243240)" by experts, given that the development process involved ensuring "robust and unbiased performance." However, the exact details of ground truth establishment specifically for the training set are not explicitly broken out as they are for the pivotal validation dataset. It's reasonable to infer a similar rigorous process if the data was used for deep learning model development.
    Ask a Question

    Ask a specific question about this device

    K Number
    K251401

    Validate with FDA (Live)

    Date Cleared
    2025-11-25

    (203 days)

    Product Code
    Regulation Number
    892.1200
    Reference & Predicate Devices
    Predicate For
    N/A
    Why did this record match?
    510k Summary Text (Full-text Search) :

    Names:** | Emission Computed Tomography System, 21 CFR 892.1200X-ray Computed Tomography, 21 CFR 892.1750

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The PennPET Explorer PET system is a diagnostic imaging device that, together with the co-located IQon CT scanner, combines Positron Emission Tomography (PET) and X-ray Computed Tomography (CT) systems. The IQon CT system images anatomical cross-sections by computer reconstruction of X-ray transmission data. The PET system images the distribution of PET anatomy-specific radiopharmaceuticals in the patient. Together, these systems are used for the purposes of detecting, localizing, diagnosing, staging, re-staging, and follow-up for monitoring therapy response of various diseases in oncology, cardiology, and neurology.

    The system is intended to image the whole body, heart, brain, lung, gastrointestinal, bone, lymphatic, and other major organs for a wide range of patient types, sizes, and extent of diseases. The CT scanner can also be operated as fully functional, independent diagnostic tool, including for use in radiation therapy planning.

    Device Description

    The PennPET Explorer is based on the PET technology of its predicate device, the Philips Vereos PET/CT scanner, but follows the model of its reference device, the previous Philips Gemini TF PET/CT by having co-located—yet separated—PET and CT scanners served by a common patient table. The PennPET Explorer uses a newly designed 142 cm axial field-of-view (AFOV) PET gantry and is intended to be used with a co-located Philips IQon multi-energy CT and patient table.

    The PennPET Explorer PET gantry is a modular system comprising six PET detector rings stacked axially, yielding a 142 cm axial FOV. This allows imaging of the human head, torso, and upper legs in a single frame without moving the patient. The entire imaging chain of components from the detectors to the data acquisition computers is supplied by Philips and consists of components that are used in the Vereos PET scanner. The mechanical structure and data processing software have been modified and developed to handle the additional data from all six PET rings simultaneously.

    Each of the six detector rings is substantially equivalent to a Philips Vereos PET scanner.

    AI/ML Overview

    N/A

    Ask a Question

    Ask a specific question about this device

    K Number
    K251798

    Validate with FDA (Live)

    Device Name
    RCT700
    Manufacturer
    Date Cleared
    2025-11-25

    (166 days)

    Product Code
    Regulation Number
    892.1750
    Reference & Predicate Devices
    Predicate For
    N/A
    Why did this record match?
    510k Summary Text (Full-text Search) :

    16882
    REPUBLIC OF KOREA

    Re: K251798
    Trade/Device Name: RCT700
    Regulation Number: 21 CFR 892.1750
    System |
    | Classification Name | Computed tomography x-ray system |
    | Regulation Number | 21 CFR 892.1750
    K213226 |
    | Classification name | Computed tomography x-ray system |
    | Regulation number | 892.1750

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    RCT700 is CBCT and panoramic x-ray imaging system with cephalometric. Which is intended to radiographic examination of the dento-maxillofacial, sinus, TMJ, Airway and ENT structure for diagnostic support for adult and pediatric patients. And a model scan is included as an option. Cephalometric image also includes wrist to obtain carpus images for growth and maturity assessment for orthodontic treatment.

    The device is to be operated and used by dentists or other legally qualified heath care professionals

    Device Description

    RCT700 provides 3D computed tomography for scanning hard tissues such as bone and teeth. By rotating the C-arm, which houses a high-voltage generator, an X-ray tube and a detector on each end, CBCT images of dental maxillofacial structures are obtained by recombining data scanned from the same level at different angles. Functionalities include panoramic image scanning for obtaining images of whole teeth, and a cephalometric option for obtaining cephalometric images.
    The software of RCT700 saves the patient and image data and offers an inquiry function, in addition, supports the image generate function intended to obtain images using the RCT700 equipment and various sensors for diagnosis.

    AI/ML Overview

    N/A

    Ask a Question

    Ask a specific question about this device

    K Number
    K251842

    Validate with FDA (Live)

    Date Cleared
    2025-11-13

    (150 days)

    Product Code
    Regulation Number
    892.1750
    Reference & Predicate Devices
    Predicate For
    N/A
    Why did this record match?
    510k Summary Text (Full-text Search) :

    K251842**
    Trade/Device Name: Dental Computed Tomography X-ray System
    Regulation Number: 21 CFR 892.1750
    Regulation Number: 21 CFR 892.1750
    Regulatory Class: Class II
    Product code: OAS
    Review Panel: Radiology
    Computed tomography x-ray system | Same |
    | Product Code | OAS | OAS | Same |
    | Regulation Number | 21 CFR 892.1750
    | 21 CFR 892.1750 | Same |
    | Indications for | The product is intended to produce X-ray Cone-Beam Computed

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The product is intended to produce X-ray Cone-Beam Computed Tomography, Panoramic tomography and Cephalometric (optional) images. The medical institutions can use the images for diagnostic purposes in oral and maxillofacial regions. The product is intended for use in hospitals and clinics, operated and used by trained professionals under the guidance of a physician.

    Device Description

    The device is used for X-ray image diagnosis of oral and maxillofacial region in medical institutions through X-ray cone-beam computed tomography, panoramic and cephalometric photography. The device is intended for use in hospitals and clinics, operated and used by trained professionals under the guidance of a physician.

    This device is divided into two models: Matrix 7000(Rubik X1), Matrix 7800(Rubik X3).

    The device is composed of X-ray tube head, plate detector, control device, positioning aid, frame, cephalometric positioning shooting aid, workstation software, etc.

    AI/ML Overview

    N/A

    Ask a Question

    Ask a specific question about this device

    K Number
    K251805

    Validate with FDA (Live)

    Date Cleared
    2025-10-15

    (125 days)

    Product Code
    Regulation Number
    892.1750
    Reference & Predicate Devices
    Predicate For
    N/A
    Why did this record match?
    510k Summary Text (Full-text Search) :

    KNOXVILLE, TN 37932

    Re: K251805
    Trade/Device Name: syngo.CT Dual Energy
    Regulation Number: 21 CFR 892.1750

    • Computed Tomography X-ray System
      Classification Panel: Radiology
      CFR Section: 21 CFR §892.1750
    • Computed Tomography X-ray System
      Classification Panel: Radiology
      CFR Section: 21 CFR §892.1750
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    syngo.CT Dual Energy is designed to operate with CT images based on two different X-ray spectra.

    The various materials of an anatomical region of interest have different attenuation coefficients, which depend on the used energy. These differences provide information on the chemical composition of the scanned body materials. syngo.CT Dual Energy combines images acquired with low and high energy spectra to visualize this information. Depending on the region of interest, contrast agents may be used.

    The general functionality of the syngo.CT Dual Energy application is as follows:

    • Bone Marrow ²⁾
    • Bone Removal ¹⁾
    • Brain Hemorrhage ¹⁾
    • Gout Evaluation ¹⁾
    • Hard Plaques ¹⁾
    • Heart PBV
    • Kidney Stones ¹⁾ ²⁾ ³⁾
    • Liver VNC ¹⁾
    • Lung Mono ¹⁾
    • Lung Perfusion ¹⁾
    • Lung Vessels ¹⁾
    • Monoenergetic ¹⁾ ²⁾
    • Monoenergetic Plus ¹⁾ ²⁾
    • Optimum Contrast ¹⁾ ²⁾
    • Rho/Z ¹⁾ ²⁾
    • SPP (Spectral Post-Processing Format) ¹⁾ ²⁾
    • SPR (Stopping Power Ratio) ¹⁾ ²⁾
    • Virtual Non-Calcium (VNCa) ¹⁾ ²⁾
    • Virtual Unenhanced ¹⁾

    The availability of each feature depends on the Dual Energy scan mode.

    ¹⁾ This functionality supports data from Siemens Healthineers Photon-Counting CT scanners acquired in QuantumPlus modes.

    ²⁾ This functionality supports data from Siemens Healthineers Photon-Counting CT scanners acquired in QuantumPeak modes.

    ³⁾ Kidney Stones is designed to support the visualization of the chemical composition of kidney stones and especially the differentiation between uric acid and non-uric acid stones. For full identification of the kidney stone, additional clinical information should be considered such as patient history and urine testing. Only a well-trained radiologist can make the final diagnosis upon consideration of all available information. The accuracy of identification is decreased in obese patients.

    Device Description

    Dual energy offers functions for qualitative and quantitative post-processing evaluations. syngo.CT Dual Energy is a post-processing application consisting of several post-processing application classes that can be used to improve the visualization of the chemical composition of various energy dependent materials in the human body when compared to single energy CT. Depending on the organ of interest, the user can select and modify different application classes or parameters and algorithms.

    Different body regions require specific tools that allow the correct evaluation of data sets. syngo.CT Dual Energy provides a range of application classes that meet the requirements of each evaluation type. The different application classes for the subject device can be combined into one workflow.

    The product is intended to be used for at least 21-year-old humans.

    AI/ML Overview

    N/A

    Ask a Question

    Ask a specific question about this device

    K Number
    K250060

    Validate with FDA (Live)

    Device Name
    GT300; GT300-C
    Manufacturer
    Date Cleared
    2025-10-08

    (271 days)

    Product Code
    Regulation Number
    892.1750
    Reference & Predicate Devices
    Predicate For
    N/A
    Why did this record match?
    510k Summary Text (Full-text Search) :

    , CA 92806

    Re: K250060
    Trade/Device Name: GT300; GT300-C
    Regulation Number: 21 CFR 892.1750
    , Dental |
    | Classification Name | Computed tomography x-ray system |
    | Regulation Number | 892.1750

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    It is intended to produce 2D (panoramic, cephalometric) or 3D (Cone Beam Computed Tomography) images. It provides diagnostic details of the dental-maxillofacial, TMJ and SINUS for adult and pediatric patients. The system also utilizes carpal images for orthodontic treatment.

    Device Description

    GT300 & GT300-C is the Diagnostic computed tomography limited view field X-ray System which consists of image acquisition modes; panorama, cephalometric, and computed tomography. It is used to capture scanned image for obtaining diagnostic information for craniofacial surgery or other treatments.

    This equipment is a device that generates and controls X-rays and consists of an X-ray generator, an X-ray control unit, an X-ray support unit, and some accessories (Chinrest, Exposure switch, Temple support, Carpus Plate).

    GT300 and GT300-C have same intended use, essential design and manufacturing. The GT300 can acquire panoramic and CT images, while the GT300-C can acquire panoramic, CT, and Cephalo images. The only difference is the presence or absence of the Cephalo feature.

    AI/ML Overview

    N/A

    Ask a Question

    Ask a specific question about this device

    K Number
    K250662

    Validate with FDA (Live)

    Device Name
    Bunkerhill MAC
    Manufacturer
    Date Cleared
    2025-10-03

    (212 days)

    Product Code
    Regulation Number
    892.1750
    Reference & Predicate Devices
    Predicate For
    N/A
    Why did this record match?
    510k Summary Text (Full-text Search) :

    WASHINGTON, DC 20004

    Re: K250662
    Trade/Device Name: Bunkerhill MAC

    Regulation Number: 21 CFR 892.1750
    Classification Name
    Regulation Number
    K243229
    Classification Name
    Regulation Number
    iCAC (K230223)**
    Product code
    Regulation number
    21 CFR §892.1750
    Modality
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Bunkerhill MAC is a software device intended for use in detecting presence and estimating quantity of mitral annulus calcification for adult patients aged 40 years and above. The device automatically analyzes non-gated, non-contrast chest computed tomography (CT) images collected during clinical care and outputs the region of interest (intended for informational purposes only) and quantification of detected calcium.

    The device-generated quantification can be viewed in the patient report at the discretion of the physician, and the physician also has the option of viewing the device-generated calcium region of interest in a diagnostic image viewer. The subject device output in no way replaces the original patient report or the original non-gated, non-contrast CT scan; both are still available to be viewed and used at the discretion of the physician.

    The device is intended to provide information to the physician to provide assistance during review of the patient's case. Results of the subject device are not intended to be used on a stand-alone basis and are solely intended to aid and provide information to the physician. In all cases, further action taken on a patient should only come at the recommendation of the physician after further reviewing the patient's results.

    Device Description

    Bunkerhill MAC is a software as a medical device (SaMD) product that interfaces with compatible and commercially available computed tomography (CT) systems. Bunkerhill MAC detects, localizes, and quantifies mitral annulus calcification in non-gated, non-contrast chest CT studies. The core features of the product are:

    • Detection of mitral annulus calcification at an Agatston-equivalent score threshold of 0 AU.
    • Quantification of the overall mitral annulus calcification burden in the form of an estimated Agatston Score up to 5000 Agatston-equivalent units
    • Localization of estimated calcium burden in the form of circular region of interest applied to a copy of the original CT scan.
    AI/ML Overview

    Here's a detailed breakdown of the acceptance criteria and the study proving the Bunkerhill MAC device meets them, based on the provided FDA 510(k) clearance letter:

    Acceptance Criteria and Reported Device Performance

    MetricAcceptance CriteriaReported Device Performance
    Positive Agreement RateDerived from predicate device performance and clinical literature on inter-reader agreement of manual segmentation (Specific numerical criteria not explicitly stated in the document, but is implied to be met successfully based on the conclusion).Met successfully
    Negative Agreement RateDerived from predicate device performance and clinical literature on inter-reader agreement of manual segmentation (Specific numerical criteria not explicitly stated in the document, but is implied to be met successfully based on the conclusion).Met successfully
    Precision (circular ROI)Derived from predicate device performance and clinical literature on inter-reader agreement of manual segmentation (Specific numerical criteria not explicitly stated in the document, but is implied to be met successfully based on the conclusion).0.885 (95% CI: 0.848, 0.919)
    Recall (circular ROI)Derived from predicate device performance and clinical literature on inter-reader agreement of manual segmentation (Specific numerical criteria not explicitly stated in the document, but is implied to be met successfully based on the conclusion).0.867 (95% CI: 0.834, 0.895)
    Bland-Altman Agreement Analysis (Bias)Derived from predicate device performance and clinical literature on inter-reader agreement of manual segmentation. (Specific numerical criteria not explicitly stated in the document, but is implied to be met successfully based on the conclusion).-6.47 AU
    Bland-Altman Agreement Analysis (Lower Limit of Agreement)Derived from predicate device performance and clinical literature on inter-reader agreement of manual segmentation. (Specific numerical criteria not explicitly stated in the document, but is implied to be met successfully based on the conclusion).-399.57 AU
    Bland-Altman Agreement Analysis (Upper Limit of Agreement)Derived from predicate device performance and clinical literature on inter-reader agreement of manual segmentation. (Specific numerical criteria not explicitly stated in the document, but is implied to be met successfully based on the conclusion).386.64 AU
    Correlation CoefficientDerived from predicate device performance and clinical literature on inter-reader agreement of manual segmentation. (Specific numerical criteria not explicitly stated in the document, but is implied to be met successfully based on the conclusion).Met successfully

    Study Details

    1. Sample Size used for the test set and the data provenance:

      • Test Set Sample Size: Not explicitly stated as a number of cases, but referred to as "the pivotal dataset."
      • Data Provenance: "curated from multiple sites across three geographical regions in the United States." (Retrospective study).
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

      • The document states "agreement of the device output compared to the established reference standard." It does not explicitly state the number of experts used or their qualifications for establishing this "established reference standard." It only refers to "clinical literature in high impact journals that investigate the inter-reader agreement of manual segmentation" as informing the acceptance criteria.
    3. Adjudication method for the test set:

      • The document does not explicitly state an adjudication method (e.g., 2+1, 3+1) for establishing the ground truth of the test set. It refers to an "established reference standard."
    4. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

      • No, a multi-reader multi-case (MRMC) comparative effectiveness study comparing human readers with AI assistance versus human readers without AI assistance was not conducted or reported in this document. The study was a "stand-alone retrospective study for detection, localization and agreement of the device output compared to the established reference standard."
    5. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

      • Yes, a standalone study was performed. The document explicitly states: "The Bunkerhill MAC performance was validated in a stand-alone retrospective study for detection, localization and agreement of the device output compared to the established reference standard."
    6. The type of ground truth used:

      • The ground truth was an "established reference standard" which was used for comparison against the device's output. The document implies this reference standard is based on non-gated CT reference measurements and potentially "manual segmentation" informed by clinical literature. It does not explicitly state pathology confirmation or direct outcomes data as the primary ground truth.
    7. The sample size for the training set:

      • The sample size for the training set is not provided in the document.
    8. How the ground truth for the training set was established:

      • The document does not provide information on how the ground truth for the training set was established. It only refers to the performance validation on a "pivotal dataset" (test set).
    Ask a Question

    Ask a specific question about this device

    K Number
    K250766

    Validate with FDA (Live)

    Device Name
    LungQ 4
    Manufacturer
    Date Cleared
    2025-10-02

    (203 days)

    Product Code
    Regulation Number
    892.1750
    Reference & Predicate Devices
    Predicate For
    N/A
    Why did this record match?
    510k Summary Text (Full-text Search) :

    NIJMEGEN, 6525 EC
    NETHERLANDS

    Re: K250766
    Trade/Device Name: LungQ 4
    Regulation Number: 21 CFR 892.1750
    Name | Computer Tomography X-ray system |
    | Product Code | JAK |
    | Classification | Class II, 21 CFR 892.1750
    | LungQ v3.0.0 |
    |------------------|---------------|
    | Predicate Classification | Class II, 21 CFR 892.1750
    -|
    | 510(k) Number | K250766 | K232412 |
    | Product Code | JAK | Same |
    | Regulation Number | 21 CFR 892.1750

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Thirona LungQ software provides reproducible CT values for pulmonary tissue and specified endobronchial implants which is essential for providing quantitative support for diagnosis, treatment planning and follow up examination. The LungQ software can be used to support physician in the diagnosis and documentation of pulmonary tissues images (e.g., abnormalities) from CT thoracic datasets. Three-D segmentation and isolation of sub-compartments, volumetric analysis, density evaluations, estimated chronic perfusion defect analysis, fissure evaluation and reporting tools are provided.

    Device Description

    The LungQ software is designed to aid in the interpretation of Computed Tomography (CT) scans of the thorax that may contain pulmonary abnormalities. LungQ is a docker image with a standalone command-line software which must be run from a command-line interpreter and does not have a graphical user interface.

    AI/ML Overview

    N/A

    Ask a Question

    Ask a specific question about this device

    K Number
    K250318

    Validate with FDA (Live)

    Device Name
    Planmed XFI
    Manufacturer
    Date Cleared
    2025-09-26

    (234 days)

    Product Code
    Regulation Number
    892.1750
    Reference & Predicate Devices
    Predicate For
    N/A
    Why did this record match?
    510k Summary Text (Full-text Search) :

    PAUL, MN 55114

    Re: K250318
    Trade/Device Name: Planmed XFI
    Regulation Number: 21 CFR 21 CFR 892.1750
    computed tomography, cone-beam
    Classification Name: Computed Tomography X-ray System (CT) (21 CFR 892.1750
    System, X-ray, Tomography, Computed
    Classification Name: Computed Tomography X-ray System (CT) (21 CFR 892.1750
    K220664 | |
    | Figure | [Device images shown] | [Device images shown] | |
    | Regulation number | 21 CFR 892.1750
    | 21 CFR 892.1750 | No difference |
    | Regulation description | Computed Tomography X-ray system | Computed

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Planmed XFI is intended to be used for cone beam computed tomography imaging of anatomies within sections of the spine, of upper extremities including shoulder(s), hand, relative joints (shoulder(s), elbow, wrist) and of lower extremities including hip(s), foot and feet, and relative joints (hip(s), knee(s), ankle(s)).

    The device is to be managed and operated/used in a professional healthcare environment by healthcare professionals and other legally qualified professionals only.

    Device Description

    The Planmed XFI X-ray unit utilizes cone beam computed tomography (CBCT) to generate three dimensional images. In CBCT imaging, a cylindrical volume of data is acquired in a single imaging procedure. This data comprises several hundred 2D images taken from various angles to encompass a specific pre-programmed target area. These images are subsequently employed for 3D reconstruction, accomplished through a dedicated PC equipped with reconstruction algorithms. The resulting reconstructed images can be visualized in three dimensions using a separate PC workstation equipped with suitable image viewer software.

    AI/ML Overview

    N/A

    Ask a Question

    Ask a specific question about this device

    K Number
    K251645

    Validate with FDA (Live)

    Date Cleared
    2025-09-26

    (120 days)

    Product Code
    Regulation Number
    892.1750
    Reference & Predicate Devices
    Predicate For
    N/A
    Why did this record match?
    510k Summary Text (Full-text Search) :

    035A; Alphenix, INFX-8000C/B, INFX-8000C/S, V9.6 with Calculated DAP
    Regulation Number: 21 CFR 892.1750
    CLASSIFICATION
    a) Classification Name: Computed Tomography X-Ray System
    b) Regulation Number: 21 CFR 892.1750
    Self-Propelled Scan Base Kit for IVR-CT, CGBA-034A (Primary Predicate) | Canon Medical Systems USA | 21 CFR 892.1750
    2018 |
    | Aquilion ONE (TSX-308A/3) V1.5 (Secondary Predicate) | Canon Medical Systems USA | 21 CFR 892.1750

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Self-Propelled CT Scan Base Kit, CGBA-035A:
    The movable gantry base unit allows the Aquilion ONE (TSX-308A) system to be installed in the same procedure room as the INFX-8000C system, enabling coordinated clinical use within a shared workspace. This configuration provides longitudinal positioning along the z-axis for image acquisition.

    Alphenix, INFX-8000C/B, INFX-8000C/S, V9.6 with Calculated DAP:
    This device is a digital radiography/fluoroscopy system used in a diagnostic and interventional angiography configuration. The system is indicated for use in diagnostic and angiographic procedures for blood vessels in the heart, brain, abdomen and lower extremities. The Calculated Dose Area Product (DAP) feature provides an alternative method for determining dose metrics without the use of a physical area dosimeter. This function estimates the cumulative reference air kerma, reference air kerma rate, and cumulative dose area product based on system parameters, including X-ray exposure settings, beam hardening filter configuration, beam limiting device position, and region of interest (ROI) filter status. The calculation method is calibration-dependent, with accuracy contingent upon periodic calibration against reference measurements.

    Device Description

    The Alphenix 4DCT is composed of the INFX-8000C interventional angiography system and the dynamic volume CT system, Aquilion ONE, TSX-308A. This combination enables patient access and efficient workflow for interventional procedures. Self-Propelled CT Scan Base Kit, CGBA-035A, is an optional kit intended to be used in conjunction with an Aquilion ONE / INFX-8000C based IVR-CT system. This device is attached to the Aquilion ONE CT gantry to support longitudinal movement and allow image acquisition in the z-direction (Z-axis), both axial and helical. When this option is installed, the standard CT patient couch is replaced with the fixed catheterization table utilized by the interventional x-ray system, INFX-8000C. The Self-Propelled CT Scan Base Kit, CGBA-035A, will be used as part of an Aquilion ONE / INFX-8000C based IVR-CT system. Please note, the intended uses of the Aquilion ONE CT System and the INFX-8000C Interventional X-Ray System remain the same. There have been no modifications made to the imaging chains in these FDA cleared devices and the base system software remains the same. Since both systems will be installed in the same room and to prevent interference during use, system interlocks have been incorporated into the systems.

    The Alphenix, INFX-8000C/B, INFX-8000C/S, V9.6 with Calculated DAP, is an interventional x-ray system with a ceiling suspended C-arm as its main configuration. Additional units include a patient table, x-ray high-voltage generator and a digital radiography system. The C-arms can be configured with designated x-ray detectors and supporting hardware (e.g. x-ray tube and diagnostic x-ray beam limiting device). The INFX-8000C system incorporates a Calculated Dose Area Product (DAP) feature, which provides an alternative method for determining dose metrics without the use of a physical area dosimeter. This function estimates the cumulative reference air kerma, reference air kerma rate, and cumulative dose area product based on system parameters, including X-ray exposure settings, beam hardening filter configuration, beam limiting device position, and region of interest (ROI) filter status. The calculation method is calibration-dependent, with accuracy contingent upon periodic calibration against reference measurements.

    AI/ML Overview

    N/A

    Ask a Question

    Ask a specific question about this device

    Page 1 of 91